Fred E Cooperrider

Array ( [id] => 7146525 [patent_doc_number] => 20050119470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Conjugated oligomeric compounds and their use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/700971 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34888 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119470.pdf [firstpage_image] =>[orig_patent_app_number] => 10700971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318721 [patent_doc_number] => 07521431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Compositions and methods for siRNA inhibition of HIF-1 alpha' [patent_app_type] => utility [patent_app_number] => 10/699557 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9732 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521431.pdf [firstpage_image] =>[orig_patent_app_number] => 10699557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308568 [patent_doc_number] => 20040142348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Proteins and polypeptides from coagulaslase-negative staphylococci' [patent_app_type] => new [patent_app_number] => 10/689082 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 22494 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142348.pdf [firstpage_image] =>[orig_patent_app_number] => 10689082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469705 [patent_doc_number] => 20040054155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Oligonucleotide compositions with enhanced efficiency' [patent_app_type] => new [patent_app_number] => 10/357826 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23552 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20040054155.pdf [firstpage_image] =>[orig_patent_app_number] => 10357826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264982 [patent_doc_number] => 20040242518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Influenza therapeutic' [patent_app_type] => new [patent_app_number] => 10/674159 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 62045 [patent_no_of_claims] => 200 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242518.pdf [firstpage_image] =>[orig_patent_app_number] => 10674159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760695 [patent_doc_number] => 20060211640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Antisense modulation of farnesoid X receptor expression' [patent_app_type] => utility [patent_app_number] => 10/670984 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 59104 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211640.pdf [firstpage_image] =>[orig_patent_app_number] => 10670984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334656 [patent_doc_number] => 20040132063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Antisense modulation of microsomal prostaglandin E2 synthase expression' [patent_app_type] => new [patent_app_number] => 10/671395 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 53119 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132063.pdf [firstpage_image] =>[orig_patent_app_number] => 10671395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169119 [patent_doc_number] => 20040077578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Antisense modulation of histone deacetylase 2 expression' [patent_app_type] => new [patent_app_number] => 10/653528 [patent_app_country] => US [patent_app_date] => 2003-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31015 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077578.pdf [firstpage_image] =>[orig_patent_app_number] => 10653528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355062 [patent_doc_number] => 20040048818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Antisense modulation of e2f transcription factor 2 expression' [patent_app_type] => new [patent_app_number] => 10/380125 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25024 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048818.pdf [firstpage_image] =>[orig_patent_app_number] => 10380125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290862 [patent_doc_number] => 20040110710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Methods of reducing ischemic injury' [patent_app_type] => new [patent_app_number] => 10/645190 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8845 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110710.pdf [firstpage_image] =>[orig_patent_app_number] => 10645190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 641839 [patent_doc_number] => 07122527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Use of antisense oligonucleotides to inhibit the expression of human Akt-1' [patent_app_type] => utility [patent_app_number] => 10/640167 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10046 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122527.pdf [firstpage_image] =>[orig_patent_app_number] => 10640167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677175 [patent_doc_number] => 20040152651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Regulation of transcription elongation factors' [patent_app_type] => new [patent_app_number] => 10/635854 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 45236 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152651.pdf [firstpage_image] =>[orig_patent_app_number] => 10635854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150935 [patent_doc_number] => 20040171564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression' [patent_app_type] => new [patent_app_number] => 10/625414 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22022 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171564.pdf [firstpage_image] =>[orig_patent_app_number] => 10625414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224329 [patent_doc_number] => 20040072726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Decoy-containing pharmaceutical compositions and method of using the same' [patent_app_type] => new [patent_app_number] => 10/466239 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7464 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072726.pdf [firstpage_image] =>[orig_patent_app_number] => 10466239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727492 [patent_doc_number] => 20060058252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Methods and materials for treating human papillomavirus infections' [patent_app_type] => utility [patent_app_number] => 10/519122 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17315 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058252.pdf [firstpage_image] =>[orig_patent_app_number] => 10519122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117189 [patent_doc_number] => 20050070490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Sos1 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/609150 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27163 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070490.pdf [firstpage_image] =>[orig_patent_app_number] => 10609150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314265 [patent_doc_number] => 20040033976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Antisense modulation of mekk3 expression' [patent_app_type] => new [patent_app_number] => 10/380127 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25049 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033976.pdf [firstpage_image] =>[orig_patent_app_number] => 10380127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931725 [patent_doc_number] => 20050282760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Antisense modulation of ptpn12 expression' [patent_app_type] => utility [patent_app_number] => 10/515538 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282760.pdf [firstpage_image] =>[orig_patent_app_number] => 10515538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311092 [patent_doc_number] => 07528116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis' [patent_app_type] => utility [patent_app_number] => 10/516342 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 48 [patent_no_of_words] => 26644 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528116.pdf [firstpage_image] =>[orig_patent_app_number] => 10516342 [rel_patent_id] =>[rel_patent_doc_number] =>)